Curtis Cluff

Biography

 Curtis was named chief executive officer of Envy Medical, Inc. in June 2009. Since that time he has led the company's successes in driving dramatic international sales growth by establishing new distribution channels/geographies, developing new products and applications for it's flagship SilkPeel medical device brand, and creating new professional skincare brands – Lumixyl®, based on Stanford developed peptide technologies, and ClarityMD for Acne. Curtis brings over 15 years of leadership, operations and finance experience, from private equity startup through Fortune-500 sized corporations. Prior to joining Envy, he was the president and COO for Colorescience Inc. (acquired by SkinMedica), establishing their medical channel strategy, and international presence from 2007 to 2009. From 2002 through 2007 he served in a number of senior executive roles for Obagi Medical Product, Inc.'s, including interim president (2003 to 2005), executive vice president of operations, chief executive of international sales & marketing, and chief financial officer. During this time, Curtis was a primary architect in building the company from a small private venture into the leading professional skincare brand in the United States, completing a successful IPO 2006 and secondary offering/exit in 2007.

Research Interest

 Dermatology